179 related articles for article (PubMed ID: 37936126)
1. Trajectories of immune-related serum proteins and quality of life in patients with pancreatic and other periampullary cancer: the CHAMP study.
Hau SO; Svensson M; Petersson A; Eberhard J; Jirström K
BMC Cancer; 2023 Nov; 23(1):1074. PubMed ID: 37936126
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy, host response and molecular dynamics in periampullary cancer: the CHAMP study.
Hau SO; Petersson A; Nodin B; Karnevi E; Boman K; Williamsson C; Eberhard J; Leandersson K; Gisselsson D; Heby M; Jirström K
BMC Cancer; 2020 Apr; 20(1):308. PubMed ID: 32293352
[TBL] [Abstract][Full Text] [Related]
3. Sex and gender differences in treatment intention, quality of life and performance status in the first 100 patients with periampullary cancer enrolled in the CHAMP study.
Olsson Hau S; Williamsson C; Andersson B; Eberhard J; Jirström K
BMC Cancer; 2023 Apr; 23(1):334. PubMed ID: 37041522
[TBL] [Abstract][Full Text] [Related]
4. Updated therapeutic outcome for patients with periampullary and pancreatic cancer related to recent translational research.
Buanes TA
World J Gastroenterol; 2016 Dec; 22(48):10502-10511. PubMed ID: 28082802
[TBL] [Abstract][Full Text] [Related]
5. Cytokeratin-positive cells in the bone marrow from patients with pancreatic, periampullary malignancy and benign pancreatic disease show no prognostic information.
Hugenschmidt H; Labori KJ; Brunborg C; Verbeke CS; Seeberg LT; Bendigtsen Schirmer C; Renolen A; Borgen E; Naume B; Wiedswang G
BMC Cancer; 2020 Nov; 20(1):1107. PubMed ID: 33198661
[TBL] [Abstract][Full Text] [Related]
6. Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: survival results and observations regarding patterns of failure, radiotherapy dose and CA19-9 levels.
Abrams RA; Grochow LB; Chakravarthy A; Sohn TA; Zahurak ML; Haulk TL; Ord S; Hruban RH; Lillemoe KD; Pitt HA; Cameron JL; Yeo CJ
Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):1039-46. PubMed ID: 10421536
[TBL] [Abstract][Full Text] [Related]
7. Pylorus-preserving pancreatoduodenectomy. Is it an adequate cancer operation.
Tsao JI; Rossi RL; Lowell JA
Arch Surg; 1994 Apr; 129(4):405-12. PubMed ID: 7908796
[TBL] [Abstract][Full Text] [Related]
8. First results from the Swedish National Pancreatic and Periampullary Cancer Registry.
Tingstedt B; Andersson B; Jönsson C; Formichov V; Bratlie SO; Öhman M; Karlsson BM; Ansorge C; Segersvärd R; Gasslander T
HPB (Oxford); 2019 Jan; 21(1):34-42. PubMed ID: 30097413
[TBL] [Abstract][Full Text] [Related]
9. Palliative pancreaticoduodenectomy in pancreatic and periampullary adenocarcinomas.
Wang SE; Shyr YM; Su CH; Chen TH; Wu CW
Pancreas; 2012 Aug; 41(6):882-7. PubMed ID: 22286381
[TBL] [Abstract][Full Text] [Related]
10. Tumour origin, diagnostic accuracy and histopathological evaluation in patients with periampullary cancer: nationwide cohort study.
Byrling J; Ghazi S; Andersson B
BJS Open; 2023 Sep; 7(5):. PubMed ID: 37864577
[TBL] [Abstract][Full Text] [Related]
11. [Surgery for periampullary pancreatic cancer].
Hank T; Klaiber U; Sahora K; Schindl M; Strobel O
Chirurg; 2021 Sep; 92(9):776-787. PubMed ID: 34259884
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of Ampullary Adenocarcinoma].
Shin DW
Korean J Gastroenterol; 2023 Oct; 82(4):159-170. PubMed ID: 37876255
[TBL] [Abstract][Full Text] [Related]
13. Preoperative misdiagnosis of pancreatic and periampullary cancer in patients undergoing pancreatoduodenectomy: A multicentre retrospective cohort study.
van Roessel S; Soer EC; Daamen LA; van Dalen D; Fariña Sarasqueta A; Stommel MWJ; Molenaar IQ; van Santvoort HC; van de Vlasakker VCJ; de Hingh IHJT; Groen JV; Mieog JSD; van Dam JL; van Eijck CHJ; van Tienhoven G; Klümpen HJ; Wilmink JW; Busch OR; Brosens LAA; Groot Koerkamp B; Verheij J; Besselink MG;
Eur J Surg Oncol; 2021 Oct; 47(10):2525-2532. PubMed ID: 33745791
[TBL] [Abstract][Full Text] [Related]
14. Histopathologic Analysis of Pancreaticoduodenectomy Specimen.
Dhakhwa R; Kafle N
JNMA J Nepal Med Assoc; 2016; 55(204):79-85. PubMed ID: 28029673
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of tumour location after adjuvant chemoradiotherapy for periampullary adenocarcinoma.
Kim K; Chie EK; Jang JY; Kim SW; Han SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
Clin Transl Oncol; 2012 May; 14(5):391-5. PubMed ID: 22551547
[TBL] [Abstract][Full Text] [Related]
16. Pancreaticojejunostomy versus pancreaticogastrostomy reconstruction after pancreaticoduodenectomy for pancreatic or periampullary tumours: a multicentre randomised trial.
Topal B; Fieuws S; Aerts R; Weerts J; Feryn T; Roeyen G; Bertrand C; Hubert C; Janssens M; Closset J;
Lancet Oncol; 2013 Jun; 14(7):655-62. PubMed ID: 23643139
[TBL] [Abstract][Full Text] [Related]
17. Surgical resection of liver metastasis in pancreatic and periampullary carcinoma.
Lopez-Lopez V; Robles-Campos R; López-Conesa A; Brusadin R; Carbonel G; Gomez-Ruiz A; Ruiz JJ; Parrilla P
Minerva Chir; 2019 Jun; 74(3):253-262. PubMed ID: 30600968
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer.
Allen VB; Gurusamy KS; Takwoingi Y; Kalia A; Davidson BR
Cochrane Database Syst Rev; 2013 Nov; (11):CD009323. PubMed ID: 24272022
[TBL] [Abstract][Full Text] [Related]
19. Periampullary adenocarcinoma: analysis of 5-year survivors.
Yeo CJ; Sohn TA; Cameron JL; Hruban RH; Lillemoe KD; Pitt HA
Ann Surg; 1998 Jun; 227(6):821-31. PubMed ID: 9637545
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase 7 expression in ampullary carcinoma.
Kumari N; Singh RK; Krishnani N; Shukla P
Indian J Pathol Microbiol; 2015; 58(3):274-8. PubMed ID: 26275245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
